129 related articles for article (PubMed ID: 16442379)
1. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins.
Sukhija R; Aronow WS; Sandhu R; Kakar P; Babu S
Am J Cardiol; 2006 Jan; 97(2):279-80. PubMed ID: 16442379
[TBL] [Abstract][Full Text] [Related]
2. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology.
Hurks R; Hoefer IE; Vink A; Pasterkamp G; Schoneveld A; Kerver M; de Vries JP; Tangelder MJ; Moll FL
Eur J Vasc Endovasc Surg; 2010 May; 39(5):569-76. PubMed ID: 20226696
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
4. Are statins an option in the management of abdominal aortic aneurysms?
Paraskevas KI; Liapis CD; Hamilton G; Mikhailidis DP
Vasc Endovascular Surg; 2008; 42(2):128-34. PubMed ID: 18421030
[TBL] [Abstract][Full Text] [Related]
5. Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.
Saratzis A; Kitas GD; Saratzis N; Melas N
Angiology; 2010 Feb; 61(2):137-44. PubMed ID: 19625274
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms.
Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Meilleur M; Sugahara T; Chalifour LE
Vasc Endovascular Surg; 2010 Feb; 44(2):116-22. PubMed ID: 20034937
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
[TBL] [Abstract][Full Text] [Related]
9. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
[TBL] [Abstract][Full Text] [Related]
10. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological therapy for patients with abdominal aortic aneurysm.
Assar AN
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):999-1009. PubMed ID: 19673677
[TBL] [Abstract][Full Text] [Related]
12. Statins enhance circulating vitamin E.
Cangemi R; Loffredo L; Carnevale R; Pignatelli P; Violi F
Int J Cardiol; 2008 Jan; 123(2):172-4. PubMed ID: 17306387
[TBL] [Abstract][Full Text] [Related]
13. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory abdominal aortic aneurysm: predictors of long-term outcome in a case-control study.
Yusuf K; Murat B; Unal A; Ulku K; Taylan K; Ozerdem O; Erdal Y; Tahsin Y
Surgery; 2007 Jan; 141(1):83-9. PubMed ID: 17188171
[TBL] [Abstract][Full Text] [Related]
16. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth.
Schouten O; van Laanen JH; Boersma E; Vidakovic R; Feringa HH; Dunkelgrün M; Bax JJ; Koning J; van Urk H; Poldermans D
Eur J Vasc Endovasc Surg; 2006 Jul; 32(1):21-6. PubMed ID: 16520071
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
Ohsfeldt RL; Gandhi SK; Fox KM; Stacy TA; McKenney JM
Am J Manag Care; 2006 Nov; 12(15 Suppl):S412-23. PubMed ID: 17112329
[TBL] [Abstract][Full Text] [Related]
19. Associations between statin treatment and markers of inflammation, vasoconstriction, and coagulation in patients with abdominal aortic aneurysm.
Gottsäter A; Flondell-Site D; Kölbel T; Lindblad B
Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):567-73. PubMed ID: 18621884
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological influencing of abdominal aortic aneurysm model - animal experimental study, primary results].
Houdek K; Moláček J; Třeška V; Tonar Z; Křížková V; Eberlová L; Baxa J; Kobr J
Rozhl Chir; 2012 Sep; 91(9):475-80. PubMed ID: 23152990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
